Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) Lansoprazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing solutions.
Patent CN104177336A details efficient asymmetric oxidation for Dexlansoprazole. Achieve high optical purity and cost reduction in pharma manufacturing.